Co-Authors
This is a "connection" page, showing publications co-authored by Markus Neurath and Georg Schett.
Connection Strength
2.579
-
COVID-19: risk for cytokine targeting in chronic inflammatory diseases? Nat Rev Immunol. 2020 05; 20(5):271-272.
Score: 0.880
-
Resolution of chronic inflammatory disease: universal and tissue-specific concepts. Nat Commun. 2018 08 15; 9(1):3261.
Score: 0.781
-
SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases. Ann Rheum Dis. 2021 10; 80(10):1312-1316.
Score: 0.236
-
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion. Nat Commun. 2020 07 24; 11(1):3774.
Score: 0.223
-
A comparative analysis of articular bone in large cohort of patients with chronic inflammatory diseases of the joints, the gut and the skin. Bone. 2018 11; 116:87-93.
Score: 0.194
-
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease. Ann Rheum Dis. 2021 10; 80(10):1339-1344.
Score: 0.059
-
IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients. Cells. 2020 12 12; 9(12).
Score: 0.057
-
Vascular occlusion by neutrophil extracellular traps in COVID-19. EBioMedicine. 2020 Aug; 58:102925.
Score: 0.056
-
Long-term Combination Therapy with Anti-TNF plus Vedolizumab Induces and Maintains Remission in Therapy-refractory Ulcerative Colitis. Am J Gastroenterol. 2017 10; 112(10):1621-1623.
Score: 0.046
-
Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells. Nat Med. 2017 Aug; 23(8):938-944.
Score: 0.045